Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine
Condition: Coronary Artery Disease Interventions: Drug: Rosuvastatin; Drug: Colchicine Sponsors: Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2023 Category: Research Source Type: clinical trials